Pharmacists warn drug shortages threaten Morocco’s health system

Just 157 medicines account for more than half of all drug reimbursements by Morocco’s health insurance funds, pharmacists warned at the 8th International Conference of the M Pharma Association, held under the theme “The Pharmacist and Humanitarian Work.”

Pharmacists said many of these medicines are often distributed outside pharmacies, making it difficult to track usage or ensure safe consumption. They called for a comprehensive review of the government decree that sets medicine prices, arguing that the current system is outdated and does not reflect the realities of the profession.

“Pharmacists must be involved in shaping health policies, and a new economic model is needed to ensure financial stability while maintaining reliable service to patients,” conference speakers said.

Past government price cuts, they noted, targeted only medium-priced drugs, prompting some laboratories to halt production and causing over 600 medicines to disappear from the market. The shortage limits access to essential treatments for ordinary citizens.

The profession also faces challenges from antiquated regulations dating back to the colonial period, which restrict pharmacists’ work and fail to address modern realities. Participants urged stricter oversight of drug sales outside official channels, warning that illegal circulation undermines public trust and endangers patients.

Pharmacists highlighted their role in humanitarian work. During the Al Haouz earthquake, they coordinated with authorities to deliver urgent medicine and aid.

International initiatives in Palestine and Gaza were also discussed, where Moroccan pharmacists delivered medicines and food despite siege conditions. Smaller projects, including digging wells in remote areas and conducting health awareness campaigns, were also cited as part of their ongoing community role.

Speakers said that without reforms in pricing, legal updates, and recognition of pharmacists’ dual professional and humanitarian responsibilities, the sector risks failing both patients and Morocco’s broader health system.